Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019
Medicine
[키워드] acute respiratory distress
Administered
antifibrotic therapy
appear
approved
ARDS
characterized
chest CT scan
clinical
compassionate use
contributed
coronavirus disease (COVID-19)
Coronavirus disease 2019
COVID-19
dosage
ECMO
endothelial
event
Factor
fibroblast
Follow-up
functional
growth factor
ILD
Interstitial lung disease
intubation
long-lasting
lung
Lung function
Lung inflammation
Lung recovery
mechanism
modulate
molecular
Nintedanib
obese patient
Patient
patients with COVID-19
Pneumonia
receptor
reflected
respiratory dysfunction
Respiratory function
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severe COVID-19
Support
Survivors
syndrome
systemic inflammation
target
targeted therapy
Treatment
Trial
Vascular
withdrawn
[DOI] 10.3389/fmed.2021.766486 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.766486 PMC 바로가기 [Article Type] Medicine